Brain Injury | Medical XPRT
Articles & Whitepapers
-
Algae toxins linked to brain diseases found in Florida
An innovative field study in Southwest Florida has identified several neurotoxins in the state’s air and water. The three forms of BMAA – beta-Methylamino-L-alanine – are associated with brain diseases. The study conducted by Calusa Waterkeeper volunteers and analysed by Wyoming’s Brain Chemistry Labs identified two forms of BMAA in every sample from 945 completed over ...
-
The Link Between Smoking and Cognitive Decline
By now, you are likely aware of many of the well-established risks associated with smoking cigarettes, such as cancer, asthma, chronic obstructive pulmonary disease (COPD), diabetes, cardiovascular ...
News
-
Wired: This startup wants to stop deaths from cardiac arrest?
In April 2013, final-year Danish medical student Habib Frost was called out to an emergency: a four-month old girl had just suffered cardiac arrest. Frost’s team tried defibrillation, but to no avail. Immediately after, the team was called out ...
Vaxxinity Receives FDA Fast Track Designation for UB-311 for Treatment of Alzheimer’s Disease
Drug developed by Galveston scientist to be tested for COVID-19 use
Neuropathix, Inc. Highlights Revenue Related to its Grant Award with NIH-NINDS
UT Health San Antonio offers summer program for people with aphasia
Equipment & Solutions
-
Showcase
Cortical Disarray Measurement (CDM) Technology
Using CDM® we will optimise patient selection, combine other clinical and patient demographics, and positively impact trial costs and performance. CDM® can estimate a patient’s pathology disease stage using grey matter quality. We provide a likelihood that a patient will progress to the next stage of disease within the next few years.
